Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

September 15, 2007 (Vol. 27, No. 16)

Expediting Biomarker Advances

miRNA, Imaging Agents, and the Burgeoning Field of Epigenomics Lead the Charge

  • Later this month, researchers will converge at the “AACR Molecular Diagnostics in Cancer Therapeutic Development” conference in Atlanta to review the newest advances in cancer biomarkers, including developments in the emerging field of epigenomics, which is expected to burgeon within the next several years as genomic data accumulates. ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.